Rivera Victor M
Department of Neurology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.
Biomedicines. 2021 Nov 3;9(11):1605. doi: 10.3390/biomedicines9111605.
The special issue on Multiple Sclerosis: Diagnosis and Treatment II, reflects advances and discoveries in the molecular and cellular mechanisms of disease, and novel laboratory techniques providing more sensitivity to diagnostic techninques and the understanding of neuroinflammation. Mitochondrial-mediated apoptosis in isolated peripheral blood mononuclear cells and the role of reactive oxygen species are studied as indicators of activity of MS. In these cells, downregulation of circular and linera RNAs are reported as markers of highly active disease in MS. Progress and importance of Neurofilaments determinations in early diagnosis and as a marker of disease activity, and the analysis of the complex mechanisms and therapeutic potential of Sphingosine-1-phosphate receptor modulator are discussed. Epidemiologic observations from a highly diversified area of the world provide more insights into this important aspect of MS; discussions on the clinical challenges posed by spinal cord involvement in demyelinatind disorders and the latest aspects of pediatric onset MS, complement this fine collection of scientific papers.
《多发性硬化症:诊断与治疗II》特刊反映了疾病分子和细胞机制方面的进展与发现,以及能提高诊断技术敏感性和增进对神经炎症理解的新型实验室技术。研究了分离的外周血单核细胞中线粒体介导的细胞凋亡以及活性氧的作用,以此作为多发性硬化症活动的指标。在这些细胞中,环状和线性RNA的下调被报告为多发性硬化症高活性疾病的标志物。讨论了神经丝测定在早期诊断中的进展和重要性以及作为疾病活动的标志物,还探讨了1-磷酸鞘氨醇受体调节剂的复杂机制和治疗潜力。来自世界高度多样化地区的流行病学观察为多发性硬化症的这一重要方面提供了更多见解;关于脊髓受累于脱髓鞘疾病所带来的临床挑战以及儿童期多发性硬化症最新情况的讨论,完善了这一优秀的科学论文集。